Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Pieris Pharma (PIRS)

5.96 0.05 (0.85%)

05-22 16:00

Open:

5.87

Pre. Close:

5.91

High:

6.2199

Low:

5.86

Volume:

498,527

Market Cap:

322M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

6.223 - 6.26

6.26 - 6.297

Low:

5.775 - 5.817

5.817 - 5.858

Close:

5.894 - 5.957

5.957 - 6.018

Technical analysis  (as of: 2018-05-22 4:42:00 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 7.36     One year: 8.10

Support:

Support1: 5.27    Support2: 4.38

Resistance:

Resistance1: 6.30    Resistance2: 6.94

Pivot:

5.90

Moving Averages:

MA(5): 5.95     MA(20): 6.01

MA(100): 7.18     MA(250): 6.10

MACD:

MACD(12,26): -0.19     Signal(12,26,9): -0.24

%K %D:

%K(14,3): 45.85     %D(3): 43.06

RSI:

RSI(14): 43.90

52-Week:

High: 9.75  Low: 3.91  Change(%): 44.0

Average Vol(K):

3-Month: 66732  10-Days 56917

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
PIRS has closed below upper band by 42.3%. Bollinger Bands are 50% narrower than normal. The narrow width of the bands suggests low volatility as compared to PIRS's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-10T14:25:06-04:00
Pieris Pharmaceuticals' (PIRS) CEO Stephen Yoder on Q1 2018 Results - Earnings Call Transcript

2018-05-10T07:09:46-04:00
Pieris Pharmaceuticals misses by $0.15, misses on revenue

2018-05-04T03:18:51-04:00
Institutional Top Ideas Series: Orbimed Advisors

2018-03-19T11:42:46-04:00
Biotech Forum Daily Digest For March 19th

2018-03-19T08:47:23-04:00
Premarket analyst action - healthcare

2018-03-16T10:25:46-04:00
Key events next week - healthcare

2018-03-12T10:30:00-04:00
Altum Is Launching Biotech Insider

2018-03-09T10:38:05-05:00
Pieris Pharmaceuticals' (PIRS) CEO Stephen Yoder on Q4 2017 Results - Earnings Call Transcript

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

53.86

Shares Float (M)

53.75

% Held by Insiders

0.20

% Held by Institutions

37.40

Shares Short (K)

2852

Shares Short Prior Month (K)

1560

Stock Financials

EPS

-0.390

EPS Est. Current Year

-0.850

EPS Est. Next Year

-0.950

EPS Est. Next Quarter

-0.220

Forward EPS

-0.700

Book Value (p.s.)

25.990

PEG Ratio

Profit Margin

-40.34

Operating Margin

-57.74

Return on Assets (ttm)

-25.4

Return on Equity (ttm)

-96.0

Qtrly Rev. Growth

565.8

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.240

Qtrly Earnings Growth

Operating Cash Flow (M)

49.75

Levered Free Cash Flow (M)

15.89

atoplab.com

Valuation

P/E

-15.28

P/E Growth Ratio

0.01

P/BV

0.23

P/S

564317888.00

P/CF

6.45

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.